Role of inflammasome in severe, steroid-resistant asthma
暂无分享,去创建一个
[1] S. Weinberg,et al. IL-17A Mediates Pyroptosis via ERK Pathway and Contributes to Steroid Resistance in CRSwNP. , 2022, The Journal of allergy and clinical immunology.
[2] I. Adcock,et al. Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. , 2021, The Journal of allergy and clinical immunology.
[3] Dong-Wook Kwak,et al. Leukotriene B4 Receptors Are Necessary for the Stimulation of NLRP3 Inflammasome and IL-1β Synthesis in Neutrophil-Dominant Asthmatic Airway Inflammation , 2021, Biomedicines.
[4] G. Koppelman,et al. The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention. , 2021, Pharmacology & therapeutics.
[5] E. Latz,et al. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death , 2021, Cellular & Molecular Immunology.
[6] Dong-Wook Kwak,et al. Leukotriene B4 receptors contribute to house dust mite-induced eosinophilic airway inflammation via TH2 cytokine production , 2021, BMB reports.
[7] Yaxue Zhao,et al. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. , 2020, Pharmacological research.
[8] X. Xia,et al. Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases , 2020, Journal of cellular physiology.
[9] Xizhe Li,et al. The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases. , 2020, Journal of dermatological science.
[10] T. Greulich,et al. Caspase-11 promotes allergic airway inflammation , 2020, Nature Communications.
[11] Xiaoxia Li,et al. Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases. , 2020, JCI insight.
[12] Wei Wei,et al. The advances in pyroptosis initiated by inflammasome in inflammatory and immune diseases , 2020, Inflammation Research.
[13] So Ri Kim,et al. Epithelial PI3K-δ Promotes House Dust Mite-Induced Allergic Asthma in NLRP3 Inflammasome-Dependent and -Independent Manners , 2020, Allergy, asthma & immunology research.
[14] D. Price,et al. Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR). , 2019, Chest.
[15] E. Lien,et al. Gasdermins and their role in immunity and inflammation , 2019, The Journal of experimental medicine.
[16] J. Lieberman,et al. Gasdermin D activity in inflammation and host defense , 2019, Science Immunology.
[17] L. Lei,et al. The role of pyroptosis in cancer: pro-cancer or pro-“host”? , 2019, Cell Death & Disease.
[18] Kenneth R. Jeffries,et al. Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects. , 2019, The Journal of allergy and clinical immunology.
[19] W. Tan,et al. Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD. , 2019, Current opinion in pharmacology.
[20] Hongmei Tan,et al. Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications , 2019, International journal of biological sciences.
[21] E. Bleecker,et al. Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma , 2019, American journal of respiratory and critical care medicine.
[22] Jae-Hong Kim,et al. Leukotriene B4 receptors mediate the production of IL‐17, thus contributing to neutrophil‐dominant asthmatic airway inflammation , 2019, Allergy.
[23] Huanwen Chen,et al. Role of pyroptosis in cardiovascular diseases. , 2019, International immunopharmacology.
[24] E. Latz,et al. Charcot–Leyden Crystals Activate the NLRP3 Inflammasome and Cause IL-1β Inflammation in Human Macrophages , 2018, The Journal of Immunology.
[25] M. Frédérich,et al. An ethnobotanical survey and inhibitory effects on NLRP3 inflammasomes/Caspase-1 of herbal recipes' extracts traditionally used in Rwanda for asthma treatment. , 2018, Journal of ethnopharmacology.
[26] C. Akdis,et al. Tight junction, mucin, and inflammasome‐related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice , 2018, Allergy.
[27] Huimei Wu,et al. Estrogen ameliorates allergic airway inflammation by regulating activation of NLRP3 in mice , 2018, Bioscience reports.
[28] F. E. Lee,et al. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease , 2018, Clinical Reviews in Allergy & Immunology.
[29] I. Chung,et al. Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells. , 2018, Biochemical and biophysical research communications.
[30] E. Bleecker,et al. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids , 2018, The Journal of allergy and clinical immunology.
[31] S. Kabra,et al. Advances in Asthma , 2018, The Indian Journal of Pediatrics.
[32] I. Mahmutovic Persson,et al. IL-1β mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation , 2018, Respiratory Research.
[33] E. Israel,et al. A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis , 2018, The Journal of allergy and clinical immunology.
[34] N. Jarjour,et al. Sputum cell IL‐1 receptor expression level is a marker of airway neutrophilia and airflow obstruction in asthmatic patients , 2017, The Journal of allergy and clinical immunology.
[35] N. Koulouris,et al. Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes , 2017, Allergy.
[36] E. Israel,et al. Severe and Difficult‐to‐Treat Asthma in Adults , 2017, The New England journal of medicine.
[37] Ryan D. Huff,et al. Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells , 2017, PloS one.
[38] Daniel C. Lazar,et al. A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. , 2017, Journal of immunological methods.
[39] L. Wood,et al. Role for NLRP3 Inflammasome‐mediated, IL‐1&bgr;‐Dependent Responses in Severe, Steroid‐Resistant Asthma , 2017, American journal of respiratory and critical care medicine.
[40] L. Wood,et al. Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma , 2017, Immunological reviews.
[41] C. Auffray,et al. Sputum transcriptomics reveal upregulation of IL‐1 receptor family members in patients with severe asthma , 2017, The Journal of allergy and clinical immunology.
[42] Wenqing Gao,et al. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.
[43] I. Adcock,et al. MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase–mediated suppression of histone deacetylase 2 , 2017, The Journal of allergy and clinical immunology.
[44] O. Herzberg,et al. Gene polymorphism linked to increased asthma and IBD risk alters gasdermin-B structure, a sulfatide and phosphoinositide binding protein , 2017, Proceedings of the National Academy of Sciences.
[45] N. Câmara,et al. Soluble Uric Acid Activates the NLRP3 Inflammasome , 2017, Scientific Reports.
[46] R. Troncoso,et al. Glucocorticoid resistance in chronic diseases , 2016, Steroids.
[47] Q. Hamid,et al. GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation , 2016, Proceedings of the National Academy of Sciences.
[48] Junjie Zhu,et al. Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS , 2016, Cell Death and Disease.
[49] V. Dixit,et al. Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.
[50] Jonathan L. Schmid-Burgk,et al. Human Monocytes Engage an Alternative Inflammasome Pathway. , 2016, Immunity.
[51] P. Gibson,et al. Neutrophil extracellular traps are associated with inflammation in chronic airway disease , 2016, Respirology.
[52] L. Borthwick. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung , 2016, Seminars in Immunopathology.
[53] D. Green,et al. Critical role of caspase-8–mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis , 2016, Mucosal Immunology.
[54] G. Dubyak,et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP , 2016, Nature Communications.
[55] D. Lang. Severe asthma: epidemiology, burden of illness, and heterogeneity. , 2015, Allergy and asthma proceedings.
[56] K. Schroder,et al. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 , 2015, European journal of immunology.
[57] S. Kummerfeld,et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.
[58] S. Zheng,et al. Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation. , 2015, Journal of molecular cell biology.
[59] P. Foster,et al. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. , 2015, The Journal of allergy and clinical immunology.
[60] G. Dubyak,et al. Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling* , 2015, The Journal of Biological Chemistry.
[61] Seamus J. Martin,et al. Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. , 2015, Immunity.
[62] E. Miao,et al. Pyroptotic cell death defends against intracellular pathogens , 2015, Immunological reviews.
[63] K. Schroder,et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.
[64] G. Dubyak,et al. Neutrophil IL-1β Processing Induced by Pneumolysin Is Mediated by the NLRP3/ASC Inflammasome and Caspase-1 Activation and Is Dependent on K+ Efflux , 2015, The Journal of Immunology.
[65] J. Fahy. Type 2 inflammation in asthma — present in most, absent in many , 2014, Nature Reviews Immunology.
[66] K. Lee,et al. NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation , 2014, Cell Death and Disease.
[67] O. Ohara,et al. Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response. , 2014, Cell reports.
[68] V. Natarajan,et al. Reactive oxygen species at the crossroads of inflammasome and inflammation , 2014, Front. Physiol..
[69] J. Tschopp,et al. The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge. , 2014, Cell reports.
[70] E. Bleecker,et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.
[71] S. Phipps,et al. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma , 2013, European Respiratory Journal.
[72] S. Johnston,et al. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung , 2013, Immunological reviews.
[73] John Calvin Reed,et al. The CARD plays a critical role in ASC foci formation and inflammasome signalling. , 2013, The Biochemical journal.
[74] P. Foster,et al. Th2 cytokine antagonists: potential treatments for severe asthma , 2013, Expert opinion on investigational drugs.
[75] A. Baccarelli,et al. Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[76] Anna K Rieger,et al. NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.
[77] B. Koller,et al. NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice , 2012, The Journal of Immunology.
[78] R. Bucala. Approaching the immunophysiology of steroid resistance , 2012, Arthritis Research & Therapy.
[79] X. Hua,et al. Analysis of NLRP3 in the Development of Allergic Airway Disease in Mice , 2012, The Journal of Immunology.
[80] B. Monsarrat,et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G , 2012, Proceedings of the National Academy of Sciences.
[81] Jinfeng Liu,et al. Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.
[82] J. Cidlowski,et al. Glucocorticoids Sensitize the Innate Immune System through Regulation of the NLRP3 Inflammasome* , 2011, The Journal of Biological Chemistry.
[83] A. Aderem,et al. Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.
[84] R. Hoffmann,et al. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells , 2011, European Respiratory Journal.
[85] P. Barnes. Biochemical Basis of Asthma Therapy* , 2011, The Journal of Biological Chemistry.
[86] M. Birrell,et al. The role of the NLRP3 inflammasome in the pathogenesis of airway disease. , 2011, Pharmacology & therapeutics.
[87] P. Foster,et al. Interleukin-13 Promotes Susceptibility to Chlamydial Infection of the Respiratory and Genital Tracts , 2011, PLoS pathogens.
[88] H. Hammad,et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. , 2011, Immunity.
[89] A. Aderem,et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.
[90] Rakesh K. Kumar,et al. IL-27/IFN-γ Induce MyD88-Dependent Steroid-Resistant Airway Hyperresponsiveness by Inhibiting Glucocorticoid Signaling in Macrophages , 2010, The Journal of Immunology.
[91] Florence Demenais,et al. A large-scale, consortium-based genomewide association study of asthma. , 2010, The New England journal of medicine.
[92] J. Martin,et al. Induction of glucocorticoid receptor‐β expression in epithelial cells of asthmatic airways by T‐helper type 17 cytokines , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[93] P. Foster,et al. Potential therapeutic targets for steroid-resistant asthma. , 2010, Current Drug Targets.
[94] D. Umetsu,et al. The many paths to asthma: phenotype shaped by innate and adaptive immunity , 2010, Nature Immunology.
[95] V. Hornung,et al. Critical functions of priming and lysosomal damage for NLRP3 activation , 2010, European journal of immunology.
[96] J. Alcorn,et al. TH17 cells in asthma and COPD. , 2010, Annual review of physiology.
[97] P. Hansbro,et al. Harnessing regulatory T cells to suppress asthma: from potential to therapy. , 2010, American journal of respiratory cell and molecular biology.
[98] Yusuke Nakamura,et al. A functional polymorphism in IL-18 is associated with severity of bronchial asthma. , 2009, American journal of respiratory and critical care medicine.
[99] D. Golenbock,et al. Inflammasomes: too big to miss. , 2009, The Journal of clinical investigation.
[100] S. Cullen,et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. , 2009, Immunity.
[101] E. Alnemri,et al. Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.
[102] J. Girard,et al. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.
[103] I. Adcock,et al. Glucocorticoid resistance in inflammatory diseases , 2009, The Lancet.
[104] C. Gabay,et al. Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage* , 2009, The Journal of Biological Chemistry.
[105] Richard A Flavell,et al. Innate instruction of adaptive immunity revisited: the inflammasome , 2009, EMBO molecular medicine.
[106] R. Nurieva,et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.
[107] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[108] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[109] J. Alcorn,et al. TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice1 , 2008, The Journal of Immunology.
[110] I. Adcock,et al. Steroid resistance in asthma: Mechanisms and treatment options , 2008, Current allergy and asthma reports.
[111] Henk C. Hoogsteden,et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.
[112] B. Cookson,et al. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.
[113] J. Douwes,et al. Innate immune activation in neutrophilic asthma and bronchiectasis , 2007, Thorax.
[114] H. Forman,et al. ATP Activates a Reactive Oxygen Species-dependent Oxidative Stress Response and Secretion of Proinflammatory Cytokines in Macrophages* , 2007, Journal of Biological Chemistry.
[115] C. Charron,et al. Mode of Glucocorticoid Actions in Airway Disease , 2006, TheScientificWorldJournal.
[116] M. Ege,et al. The asthma epidemic. , 2006, The New England journal of medicine.
[117] G. Lukács,et al. Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.
[118] I. Adcock,et al. Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression , 2006, The Journal of experimental medicine.
[119] J. Cidlowski,et al. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.
[120] P. Chanez. Severe asthma is an epithelial disease , 2005, European Respiratory Journal.
[121] I. Adcock,et al. Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases , 2005, COPD.
[122] Alejandra Bruna,et al. Glucocorticoid receptor–JNK interaction mediates inhibition of the JNK pathway by glucocorticoids , 2003, The EMBO journal.
[123] Lung-Chi Chen,et al. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. , 2003, American journal of respiratory cell and molecular biology.
[124] A. V. van Kuilenburg,et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.
[125] Lung-Chi Chen,et al. Size fractions of ambient particulate matter induce granulocyte macrophage colony-stimulating factor in human bronchial epithelial cells by mitogen-activated protein kinase pathways. , 2002, American journal of respiratory cell and molecular biology.
[126] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[127] J. Fahy,et al. Remodeling of the airway epithelium in asthma. , 2001, American journal of respiratory and critical care medicine.
[128] J. Hogg,et al. Particulate matter induces cytokine expression in human bronchial epithelial cells. , 2001, American journal of respiratory cell and molecular biology.
[129] J. Cidlowski,et al. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. , 1999, The Journal of biological chemistry.
[130] S. Wenzel,et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.
[131] R. Kamen,et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production , 1997, Nature.
[132] K. Horwitz,et al. Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.
[133] P. Barnes,et al. Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.
[134] R. Kimberly. Glucocorticoids , 2020, Reactions Weekly.
[135] K. O. Elliston,et al. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.
[136] Dirk E. Smith,et al. The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm. , 2015, American journal of respiratory cell and molecular biology.
[137] J. Tschopp,et al. The Inflammasomes , 2010, Cell.
[138] P. Hart,et al. S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. , 2007, The Journal of allergy and clinical immunology.